Preparation of UiO-66 loaded Letrozole nano-drug delivery system: enhanced anticancer and apoptosis activity

AMB Express - Tập 14 Số 1
Maryam Ronaghi1, Ramtin Hajibeygi2, Reza Ghodsi3, Akram Eidi1, Ronak Bakhtiari4
1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Science, Tehran, Iran
3Department of Chemical and Petrochemical Engineering, Sharif University of Technology, Tehran, Iran
4Department of Pathobiology, Division of Microbiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Tóm tắt

AbstractThe use of drug delivery systems in targeting and achieving the targeting of drugs in treating diseases, especially cancer, has attracted the attention of researchers. Letrozole is one of the drugs for the treatment of breast cancer. In this study, the organic-metallic pharmaceutical porous nanostructure based on zirconium UiO-66 loaded letrozole was synthesized. Its cytotoxicity and effect on apoptosis and migration against breast cancer cell line were investigated. In this experimental study, the UiO-66 nanoparticle-loaded letrozole was synthesized using zirconium chloride (ZrCl4), dimethylformamide (DMF), and HCl. Its characteristics were determined by scanning electron microscopy, and its average size was determined by the DLS method. Also, the rate of letrozole drug release from the nanoparticle was investigated in 24, 48, and 72 h. In addition, its cytotoxicity effects were investigated using the MTT colorimetric method at concentrations of 3.125-100 µg/ml against the breast cancer cell line (MCF-7) in the periods of 48 and 72 h. Also, the expression level of apoptotic genes Bax and Bcl2 was investigated by the Real-Time PCR method. Also, the amount of cell migration was done by the migration assay method. The results showed that UiO-66 bound to letrozole had a spherical morphology and an average size of 9.2 ± 160.1. Also, the letrozole drug was loaded by 62.21 ± 1.80% in UiO-66 nanoparticles and had a slower release pattern than free letrozole in the drug release test, so within 72 h, 99.99% of free letrozole was released in If in UiO-66 containing letrozole, 57.55% of the drug has been released. Also, the cytotoxicity results showed that UiO-66 bound to letrozole has more significant cytotoxic effects than free letrozole (p < 0.05). Also, the results of Bax and Bcl2 gene expression showed that the treatment of MCF-7 cells with UiO-66 nanoparticles attached to letrozole increased the expression of Bax and Bcl2 genes compared to the reference gene Beta-actin in MCF-7 cell line, respectively. (p < 0.05) increased by 3.71 ± 0.42 and (p < 0.01) decreased by 0.636 ± 0.034 (p < 0.05). Cell migration results showed that the concentration of 50 µg/ml of UiO-66 bound to letrozole decreased the migration of MCF-7 cells. Generally, the results of this study showed that UiO-66 loaded letrozole can be used as a suitable drug carrier for cellular purposes, as it has increased the effects of cytotoxicity and the rate of apoptosis in breast cancer cell line (MCF-7), so it can be used with more studies used nanocarriers as a drug delivery system.

Từ khóa


Tài liệu tham khảo

Abazari R, Mahjoub AR, Ataei F, Morsali A, Carpenter-Warren CL, Mehdizadeh K, J. I. AM, Slawin C (2018) Chitosan immobilization on bio-MOF nanostructures: a biocompatible pH-responsive nanocarrier for doxorubicin release on MCF-7 cell lines of human breast cancer. 57(21): 13364–13379

Ahmadi S, Seraj M, Chiani M, Hosseini S, Bazzazan S, Akbarzadeh I, S. Saffar and E. J. I. J. o. N., Mostafavi (2022) In vitro development of controlled-release nanoniosomes for improved delivery and anticancer activity of letrozole for breast cancer treatment. 6233–6255

Akbarzadeh I, Poor AS, Khodarahmi M, Abdihaji M, Moammeri A, Jafari S, Moghaddam ZS, Seif M, Moghtaderi M, Lalami ZAJM, Materials M (2022) Gingerol/letrozole-loaded mesoporous silica nanoparticles for breast cancer therapy: In-silico and in-vitro studies. 337:111919

Amale FR, Ferdowsian S, Hajrasouliha S, Kazempoor R, Mirzaie A, Dakkali MS, Akbarzadeh I, Meybodi SM, A. MJ, Mirghafouri (2021) Gold nanoparticles loaded into niosomes: a novel approach for enhanced antitumor activity against human ovarian cancer. 32(12):4711–4722

Amer Ridha A, Kashanian S, Rafipour R, Hemati Azandaryani A, Zhaleh H (2021) E. J. P. d. Mahdavian and technology A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate–apoferritin-conjugated cationic solid lipid nanoparticles. 26(6): 673–681

Asadipour E, Asgari M, Mousavi P, Piri-Gharaghie T, Ghajari G, Mirzaie AJC and Biodiversity (2023) Nano‐Biotechnology and challenges of Drug Delivery System in Cancer Treatment Pathway. e202201072

Bazzazan S, Moeinabadi-Bidgoli K, Lalami ZA, Bazzazan S, Mehrarya M, Yeganeh FE, Hejabi F, Akbarzadeh I, Noorbazargan H (2023) M. J. J. o. D. D. S. Jahanbakhshi and Technology Engineered UIO-66 metal-organic framework for delivery of curcumin against breast cancer cells: An in vitro evaluation. 79: 104009

Butova VV, e. MA, Soldatov AA, Guda KA, Lomachenko, Lamberti C (2016) Metal-organic frameworks: structure, properties, methods of synthesis and characterization. Rus Chem Rev 85(3):280

Cai M, Chen G, Qin L, Qu C, Dong X, Ni J, Yin X (2020) Metal Organic frameworks as Drug Targeting Delivery vehicles in the treatment of Cancer. Pharmaceutics 12(3):232

Chen H, Fu Y, Feng K, Zhou Y, Wang X, Huang H, Chen Y, Wang W, Xu Y, Tian H (2021) Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy. J Nanobiotechnol 19:1–18

Dinda C, S. and, Pattnaik G (2013) Nanobiotechnology-based drug delivery in brain targeting. Curr Pharm Biotechnol 14(15):1264–1274

Farboudi A, Mahboobnia K, Chogan F, Karimi M, Askari A, Banihashem S, Davaran S, Irani M (2020) UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid. Int J Biol Macromol 150:178–188

Frandsen SK, McNeil AK, Novak I, McNeil PL, Gehl J (2016) Difference in membrane repair capacity between cancer cell lines and a normal cell line. J Membr Biol 249:569–576

Garmarudi AB, Ghasemi K, Mozaffari F, Khorani M, Khanmohammadi M (2015). Most common techniques of outlier detection. Current applications of chemometrics.

Gholami M, Hekmat A, Khazaei M, Darroudi M (2022) OXA-CuS@ UiO-66-NH2 as a drug delivery system for oxaliplatin to colorectal cancer cells. J Mater Science: Mater Med 33(3):26

Giliopoulos D, Zamboulis A, Giannakoudakis D, Bikiaris D, Triantafyllidis K (2020) Polymer/metal organic framework (MOF) nanocomposites for biomedical applications. Molecules 25(1):185

Gomhor J, Alqaraghuli H, Kashanian S, Rafipour R, Mahdavian E (2018) K. J. a. c. Mansouri, Nanomedicine, and biotechnology Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells. 46(sup3): 847–854

Gotow T, Shibata M, Kanamori S, Tokuno O, Ohsawa Y, Sato N, Isahara K, Yayoi Y, Watanabe T, Leterrier JJCD and Differentiation (2000) Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells. 7(7):666–674

Haddadian A, Robattorki FF, Dibah H, Soheili A, Ghanbarzadeh E, Sartipnia N, Hajrasouliha S, Pasban K, Andalibi R (2022) and M. H. J. S. r. Ch Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. 12(1): 21938

Hemati Azandaryani A, Kashanian S, J. P. r. Derakhshandeh K (2017) Folate conjugated hybrid nanocarrier for targeted letrozole delivery in breast cancer treatment. 34:2798–2808

Hidayat ARP, Zulfa LL, Widyanto AR, Abdullah R, Kusumawati Y, Ediati R (2023) Selective adsorption of anionic and cationic dyes on mesoporous UiO-66 synthesized using a template-free sonochemistry method: kinetic, isotherm and thermodynamic studies. RSC Adv 13(18):12320–12343

Hojabri M, Tayebi T, Kasravi M, Aghdaee A, Ahmadi A, Mazloomnejad R, Tarasi R, Shaabani A, Bahrami S (2023) and H. J. I. J. o. B. M. Niknejad Wet-spinnability and crosslinked Fiber properties of alginate/hydroxyethyl cellulose with varied proportion for potential use in tendon tissue engineering. 240: 124492

Horcajada P, Chalati T, Serre C, Gillet B, Sebrie C, Baati T, Eubank JF, Heurtaux D, Clayette P, Kreuz C (2010) Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 9(2):172–178

Jarai BM, Stillman Z, Attia L, Decker GE, Bloch ED, Fromen CA (2020) Evaluating UiO-66 metal–organic framework nanoparticles as acid-sensitive carriers for pulmonary drug delivery applications. ACS Appl Mater Interfaces 12(35):38989–39004

Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D (1998) J. P. o. t. N. A. o. S. Reed. Bax Directly Induces Release Cytochrome c Isolated Mitochondria 95(9):4997–5002

Kasravi M, Yaghoobi A, Tayebi T, Hojabri M, Taheri AT, Shirzad F, Nooshin BJ, Mazloomnezhad R, Ahamadi A and F. A., Tehrani (2023) MMP inhibition as a novel strategy for extracellular matrix preservation during whole liver decellularization. 213710

Khatibi Z, Kazemi NM, Khaleghi S (2022) Targeted and biocompatible NMOF as efficient nanocomposite for delivery of methotrexate to colon cancer cells. Journal of Drug Delivery Science (Technology). 103441

Lázaro IA, Forgan RS (2019) Application of zirconium MOFs in drug delivery and biomedicine. Coord Chem Rev 380:230–259

Liang Y-J, Hao Q, Wu Y-Z, Wang Q-L, Wang J-D, Hu Y-L (2009) Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth. International Journal of Gynecologic Cancer 19(7): 1248-1252-1248-1252

Lisztwan J, Pornon A, Chen B, Chen S, Evans DB (2008) The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer. Breast Cancer Res 10:1–13

Mansouri M, Khayam N, Jamshidifar E, Pourseif T (2021) Streptomycin sulfate–loaded Niosomes enables increased antimicrobial and anti-biofilm activities. Front Bioeng Biotechnol. 2021; 9

Meng Z, Huang H, Huang D, Zhang F, Mi P (2021) Functional metal–organic framework-based nanocarriers for accurate magnetic resonance imaging and effective eradication of breast tumor and lung metastasis. J Colloid Interface Sci 581:31–43

Miller W, Anderson T, Dixon J (2002) Anti-tumor effects of letrozole. Cancer Invest 20(sup2):15–21

Mirzaie A, Badmasti F, Dibah H, Hajrasouliha S, Yousefi F, Andalibi R, Kashtali AB, A. H. Rezaei and R. J. I. J. o. P. H., Bakhtiatri (2022) Phyto-Fabrication of silver nanoparticles using Typha azerbaijanensis aerial part and root extracts. 51(5): 1097

Moammeri A, Jamshidifar E, Abbaspour K, Sadeghi S, Lamakani L, Akbarzadeh I (2021) Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: enhanced antibacterial and anti-biofilm activities. Bioorg Chem. 105116.

Moammeri A, Chegeni MM, Sahrayi H, Ghafelehbashi R, Memarzadeh F, Mansouri A, Akbarzadeh I, Hejabi F, Abtahi MS and Q., Ren (2023) Current advances in niosomes applications for drug delivery and cancer treatment. 100837

Mocniak KA, Kubajewska I, Spillane DE, Williams GR (2015) and R. E. J. R. a. Morris Incorporation of cisplatin into the metal–organic frameworks UiO66-NH 2 and UiO66–encapsulation vs. conjugation. 5(102): 83648–83656

Molani S, Madadi M, Wilkes W (2019) A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: incorporating uncertainty in patients adherence behaviors. Omega 89:40–53

Molavi H, Zamani M, Aghajanzadeh M, Kheiri Manjili H, Danafar H, Shojaei A (2018) Evaluation of UiO-66 metal organic framework as an effective sorbent for Curcumin’s overdose. Appl Organomet Chem 32(4):e4221

Nasrabadi M, Ghasemzadeh MA, Monfared MRZ (2019) The preparation and characterization of UiO-66 metal–organic frameworks for the delivery of the drug ciprofloxacin and an evaluation of their antibacterial activities. New J Chem 43(40):16033–16040

Nilash MM, Hashemzadeh A, Fakhari AR, Amini MM (2019) Novel Schiff base-functionalized metal–organic framework nanoparticles for dispersive solid phase extraction of copper ions from vegetable and water samples. Anal Methods 11(20):2683–2691

Noorbazargan H, Amintehrani S, Dolatabadi A, Mashayekhi A, Khayam N, Moulavi P, Naghizadeh M, Mirzaie A, Mirzaei Rad F, Kavousi MJAE (2021) Anti-cancer & anti-metastasis properties of bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract against lung cancer cells. 11(1):61

Pourmoghadasiyan B, Tavakkoli F, Beram FM, Badmasti F, Mirzaie A, Kazempour R, Rahimi S, Larijani SF, Hejabi F, M. KJ, Sedaghatnia BR (2022) Nanosized paclitaxel-loaded niosomes: Formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines. 49(5):3597–3608

Rabiei M, Kashanian S, Samavati SS, Jamasb S (2020) J. J. o. d. t. McInnes. Nanomaterial Adv Technol Transdermal drug Delivery 28(4):356–367

Rakhshani N, Hassanzadeh Nemati N, Ramezani Saadatabadi A, J. I. S, Sadrnezhaad (2021) Fabrication and evaluation of controlled release of Doxorubicin loaded UiO-66-NH2 metal organic frameworks. 34(8):1874–1881

Sadek AA, Abd-Elkareem M, Abdelhamid HN, Moustafa S, Hussein K (2022) Enhancement of critical-sized bone defect regeneration using UiO-66 nanomaterial in rabbit femurs. BMC Vet Res 18(1):260

Salekshahrezaee Z, Leevy JL, Khoshgoftaar TM (2021) A reconstruction error-based framework for label noise detection. J Big Data 8(1):1–16

Sartorius UA, Krammer PH (2002) Upregulation of bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. 97(5): 584–592

Simpson D, Curran MP, Perry CM (2004) Letrozole: a review of its use in postmenopausal women with breast cancer. Drugs 64:1213–1230

Singh R, Letai A, Sarosiek (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. 20(3): 175–193

Sun C-Y, Qin C, Wang X-L, Su Z-M (2013) Metal-organic frameworks as potential drug delivery systems. Expert Opin Drug Deliv 10(1):89–101

Tiwari G, Tiwari R, Sriwastawa B, Bhati L, Pandey S, Pandey P, Bannerjee SK (2012) Drug delivery systems: an updated review. Int J Pharm Invest 2(1):2

Trushina DB, Sapach AY, Burachevskaia OA, Medvedev PV, Khmelenin DN, Borodina TN, Soldatov MA, Butova VV (2022) Doxorubicin-loaded core–shell UiO-66@ SiO2 metal–organic frameworks for targeted cellular uptake and cancer treatment. Pharmaceutics 14(7):1325

Waks AG, Winer EP (2019) Breast cancer treatment: a review. JAMA 321(3):288–300

Wang C, Youle RJ (2009) The role of mitochondria in apoptosis. Annu Rev Genet 43:95–118

Westphal D, Dewson G, Czabotar PE (2011) J. B. e. B. A.-M. C. R. Kluck. Mol Biology Bax Bak Activation Action 1813(4):521–531

Wood WG, Igbavboa U, Muller WE, Eckert GP (2013) Statins, Bcl-2, and apoptosis: cell death or cell protection? Mol Neurobiol 48(2):308–314

Wu W, Pu Y, Shi J (2022) Nanomedicine-enabled chemotherapy-based synergetic cancer treatments. J Nanobiotechnol 20(1):1–21

Yoon O, Roh J (2012) Downregulation of KLF4 and the Bcl-2/Bax ratio in advanced epithelial ovarian cancer. Oncol Lett 4(5):1033–1036

Zhang Z-J, Li P-W, Liu L-P, Ru L-H, Tang H-X, Feng W-S (2022) Amine-functionalized UiO-66 as a fluorescent sensor for highly selective detecting volatile organic compound biomarker of lung cancer. J Solid State Chem 305:122623